TBK1 and non-small cell lung carcinoma: In a non-small cell lung cancer (NSCLC) study, a subset of cancer cells exhibited sensitivity to TBK1 inhibition, which was correlated with activation of Akt and mTORC1 (mechanistic target of rapamycin complex 1) signaling [43].